PlainRecalls
FDA Devices Moderate Class II Terminated

Dimension Vista Enzymatic Creatinine (ECREA) reagent, SMN 10700444

Reported: February 26, 2020 Initiated: December 18, 2019 #Z-1233-2020

Product Description

Dimension Vista Enzymatic Creatinine (ECREA) reagent, SMN 10700444

Reason for Recall

There is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.

Details

Units Affected
11,725 units
Distribution
US Nationwide
Location
Tarrytown, NY

Frequently Asked Questions

What product was recalled?
Dimension Vista Enzymatic Creatinine (ECREA) reagent, SMN 10700444. Recalled by Siemens Healthcare Diagnostics, Inc.. Units affected: 11,725 units.
Why was this product recalled?
There is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 26, 2020. Severity: Moderate. Recall number: Z-1233-2020.